BioVersys announces first patient first visit in Phase 2b RIV-CARE trial of BV100
RIV-CARE will enrol approximately 100 patients with suspected or confirmed hospital-acquired bacterial pneumonia (HABP), ventilator-associated bacterial pneumonia (VABP) and bloodstream…
